Straumann Group Reports Robust Organic Growth in Q3 2024

Straumann Holding AG announced a notable 11.2% organic revenue increase in Q3 2024, reaching CHF 585.5 million. This growth brings the year-to-date revenue to approximately CHF 1.9 billion, with a 14.5% organic rise. The Europe, Middle East, and Africa region notably contributed with an 11.4% organic increase in the quarter. Meanwhile, Asia Pacific stood out with the highest regional growth of 19.7%, driven by strong implantology performance. North America saw modest growth of 2.0%, despite a challenging implantology market. Latin America maintained its strength with an 18.9% organic growth, notably through the Neodent brand.

Straumann also highlighted strategic advances, including the global launch of the SIRIOS intraoral scanner and ongoing investments in capacity expansion, notably a new Neodent factory in Brazil. CEO Guillaume Daniellot expressed confidence in sustaining growth, reaffirming the 2024 outlook for low double-digit organic revenue growth and 27-28% profitability.